The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, and the rising prevalence of chronic diseases. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.
The assays, kits, & reagents accounted for the highest growth rate in the pyrogen testing market, by product & service, during the forecast period The pyrogen testing market is segmented into assays, kits, & reagents, instruments, and services based on product & service.The assays, kits, & reagents segment accounted for the highest growth rate in the pyrogen testing market in 2019.
The requirement of assays, kits, & reagents in large numbers compared to instruments is the main factor contributing to this segment’s high growth rate. This segment’s market growth can also be attributed to repeat purchases of assays, kits, & reagents compared to instruments and the rising preference for kit-based testing.
LAL tests segment accounted for the highest CAGR Based on the test type, the pyrogen testing market is segmented into LAL tests, in vitro tests, and rabbit tests.The LAL tests segment is further categorized into chromogenic tests, turbidimetric tests, and gel clot tests.
In 2019, the LAL tests segment accounted for the highest growth rate. The rising need for innovative laboratory testing procedures, increasing health standards, growing drug pipelines, and the increasing support for vaccine development are the major factors driving this segment’s growth.
Pharmaceutical & biotechnology companies segment accounted for the highest CAGR Based on end-users, the pyrogen testing market is segmented into pharmaceutical & biotechnology companies, medical device companies, and other end users.In 2019, the pharmaceutical & biotechnology companies segment accounted for the highest growth rate.
This can be attributed to many ongoing drug discovery activities and the increasing number of R&D facilities globally.
Asia Pacific: The fastest-growing region pyrogen testing market The global pyrogen testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.The Asia Pacific region is projected to register the highest CAGR during the forecast period.
Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the pyrogen testing market in this region.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%
Lits of Companies Profiled in the Report: • Charles River Laboratories, Inc. (US) • Lonza (Switzerland) • Merck KGaA (Germany) • Thermo Fisher Scientific, Inc. (US) • Associates of Cape Cod, Inc. (US) • GenScript Biotech Corporation (China) • bioMérieux SA (France) • FUJIFILM Wako Pure Chemical Corporation (Japan) • Eurofins Scientific (Luxembourg) • WuXi AppTec (China) • Hycult Biotech (Netherlands) • Ellab A/S (Denmark) • Microcoat Biotechnologie GmbH (Germany) • InvivoGen (US) • Nelson Laboratories, LLC (US) • Almac Group (UK) • Pacific Biolabs (US) • STERIS plc (US) • Accugen Laboratories, Inc. (US) • TOXIKON (US) • Minerva Analytix GmbH (Germany) • Indoor Biotechnologies, Inc. (US) • Creative Bioarray (US) • Lucideon Limited (UK) • North American Science Associates, Inc. (US)
Research Coverage: This report provides a detailed picture of the global pyrogen testing market.It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, end user, and region.
The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pyrogen testing market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar hormones market are Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals and GC Pharma. The global biosimilar hormones market is expected to decline from $2.05 billion in 2019 to $1.94 billion in 2020 at a compound...
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1% during the forecast period. Market growth is driven by factors such as growth in stem cell research, increasing R&D in the pharmaceutical and biotechnology industries for complex diseases, rising prevalence...
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative...
286 pages •
By The Business Research Company
• Nov 2020
CRISPR Technology Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global CRISPR technology market. Description: Where is the largest and fastest growing market for the CRISPR...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of House Dust Mite Allergy Clinical trials scenario.This report provides top line data relating...
Biopharmaceutical Fermentation System Market Research Report by Product (Downstream Process Product and Upstream Process Product), by Application (Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. Technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.